1887

Abstract

spp. infections are a serious health problem, especially in patients with risk factors. The acquisition of resistance, often associated with biofilm production, makes treatment more difficult due to the reduced effectiveness of available antifungals. Drug repurposing is a good alternative for the treatment of infections by spp. biofilms. The present study evaluated the antibiofilm activity of sertraline in reducing the cell viability of forming and matured biofilms, in addition to elucidating whether effective concentrations are safe. Sertraline reduced biofilm cell viability by more than 80 % for all species tested, acting at low and safe concentrations, both on mature biofilm and in preventing its formation, even the one with highest virulence. Its preventive mechanism seemed to be related to binding with ALS3. These data indicate that sertraline is a promising drug with anticandidal biofilm potential in safe doses. However, further studies are needed to elucidate the antibiofilm mechanism and possible application of pharmaceutical forms.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001664
2023-02-09
2024-12-02
Loading full text...

Full text loading...

References

  1. Zhou L-H, Jiang Y-K, Li R-Y, Huang L-P, Yip C-W et al. Risk-based estimate of human fungal disease burden, China. Emerg Infect Dis 2020; 26:2137–2147 [View Article]
    [Google Scholar]
  2. Ghazi S, Rafei R, Osman M, El Safadi D, Mallat H et al. The epidemiology of Candida species in the Middle East and North Africa. J Mycol Med 2019; 29:245–252 [View Article]
    [Google Scholar]
  3. Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Rev Dis Primers 2018; 4:18026 [View Article]
    [Google Scholar]
  4. Almeida F, Rodrigues ML, Coelho C. The still underestimated problem of fungal diseases worldwide. Front Microbiol 2019; 10:214 [View Article]
    [Google Scholar]
  5. Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 2018; 360:739–742 [View Article]
    [Google Scholar]
  6. Ye N, Liu Z, Tang W, Li X, Chu W et al. Systematic characterization of epidemiology, antifungal susceptibility, risk factors and outcomes of Candidaemia: a six-year Chinese study. Infect Drug Resist 2022; 15:4887–4898 [View Article]
    [Google Scholar]
  7. Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997-2016. Open Forum Infect Dis 2019; 6:S79–S94 [View Article]
    [Google Scholar]
  8. Rodrigues ME, Gomes F, Rodrigues CF. Candida spp./bacteria mixed biofilms. J Fungi 2020; 6:5 [View Article]
    [Google Scholar]
  9. Nett JE, Andes DR. Contributions of the biofilm matrix to Candida pathogenesis. J Fungi 2020; 6:21 [View Article]
    [Google Scholar]
  10. Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 2013; 62:10–24 [View Article]
    [Google Scholar]
  11. Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 2019; 18:41–58 [View Article]
    [Google Scholar]
  12. Oliveira AS, Martinez-de-Oliveira J, Donders GGG, Palmeira-de-Oliveira R, Palmeira-de-Oliveira A. Anti-Candida activity of antidepressants sertraline and fluoxetine: effect upon pre-formed biofilms. Med Microbiol Immunol 2018; 207:195–200 [View Article]
    [Google Scholar]
  13. Pierce CG, Uppuluri P, Tristan AR, Wormley FL Jr, Mowat E et al. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 2008; 3:1494–1500 [View Article] [PubMed]
    [Google Scholar]
  14. Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Third Edition M27-A3 [Internet]; 2008 www.clsi.org
  15. Xie Y, Liu X, Zhou P. In vitro antifungal effects of berberine against Candida spp. In planktonic and biofilm conditions. Drug Des Devel Ther 2020; 14:87–101 [View Article]
    [Google Scholar]
  16. Gurgel do Amaral Valente Sá L, da Silva CR, Neto JB de A, do Nascimento FBSA, Barroso FDD et al. Antifungal activity of etomidate against growing biofilms of fluconazole-resistant Candida spp. strains, binding to mannoproteins and molecular docking with the ALS3 protein. J Med Microbiol 2020; 69:1221–1227 [View Article]
    [Google Scholar]
  17. Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminform 2012; 4:17 [View Article]
    [Google Scholar]
  18. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM et al. UCSF Chimera--A visualization system for exploratory research and analysis. J Comput Chem 2004; 25:1605–1612 [View Article] [PubMed]
    [Google Scholar]
  19. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010; 31:455–461 [View Article]
    [Google Scholar]
  20. Marinho EM, Batista de Andrade Neto J, Silva J, Rocha da Silva C, Cavalcanti BC et al. Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease. Microb Pathog 2020; 148:104365 [View Article]
    [Google Scholar]
  21. Yusuf D, Davis AM, Kleywegt GJ, Schmitt S. An alternative method for the evaluation of docking performance: RSR vs RMSD. J Chem Inf Model 2008; 48:1411–1422 [View Article]
    [Google Scholar]
  22. Trincao J, Johnson RE, Escalante CR, Prakash S, Prakash L et al. Structure of the catalytic core of S. cerevisiae DNA polymerase η. Molecular Cell 2001; 8:417–426 [View Article]
    [Google Scholar]
  23. Znosko BM, Kennedy SD, Wille PC, Krugh TR, Turner DH. Structural features and thermodynamics of the J4/5 loop from the Candida albicans and Candida dubliniensis group I introns. Biochemistry 2004; 43:15822–15837 [View Article]
    [Google Scholar]
  24. Cavalcanti BC, do Amaral Valente Sá LG, de Andrade Neto JB, de Sousa Silva AA, Rios MEF et al. Etomidate is devoid of genotoxicty and mutagenicity in human lymphocytes and in the Salmonella typhimurium/microsomal activation test. Toxicol In Vitro 2020; 68:104946 [View Article]
    [Google Scholar]
  25. Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence 2018; 9:522–554 [View Article]
    [Google Scholar]
  26. Černáková L, Light C, Salehi B, Rogel-Castillo C, Victoriano M et al. Novel therapies for biofilm-based Candida spp infections. In Advances in Experimental Medicine and Biology Springer; 2019 pp 93–123
    [Google Scholar]
  27. Kean R, McKloud E, Townsend EM, Sherry L, Delaney C et al. The comparative efficacy of antiseptics against Candida auris biofilms. Int J Antimicrob Agents 2018; 52:673–677 [View Article]
    [Google Scholar]
  28. Gowri M, Jayashree B, Jeyakanthan J, Girija EK. Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro. J Appl Microbiol 2020; 128:426–437 [View Article]
    [Google Scholar]
  29. Melo AS, Bizerra FC, Freymüller E, Arthington-Skaggs BA, Colombo AL. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol 2011; 49:253–262 [View Article]
    [Google Scholar]
  30. Turan H, Demirbilek M. Biofilm-forming capacity of blood-borne Candida albicans strains and effects of antifungal agents. Rev Argent Microbiol 2018; 50:62–69 [View Article]
    [Google Scholar]
  31. Kioshima ES, Shinobu-Mesquita CS, Abadio AKR, Felipe MSS, Svidzinski TIE et al. Selection of potential anti-adhesion drugs by in silico approaches targeted to ALS3 from Candida albicans. Biotechnol Lett 2019; 41:1391–1401 [View Article]
    [Google Scholar]
  32. de Barros PP, Rossoni RD, de Souza CM, Scorzoni L, Fenley JDC et al. Candida biofilms: an update on developmental mechanisms and therapeutic challenges. Mycopathologia 2020; 185:415–424 [View Article]
    [Google Scholar]
  33. Oh S-H, Isenhower A, Rodriguez-Bobadilla R, Smith B, Jones J et al. Pursuing advances in DNA sequencing technology to solve a complex genomic Jigsaw puzzle: the Agglutinin-Like Sequence (ALS) genes of Candida tropicalis. Front Microbiol 2020; 11:594531 [View Article]
    [Google Scholar]
  34. Zhang T, Vanderghinste J, Guidetti A, Doorslaer SV, Barcaro G et al. Pi-Pi stacking complex induces three‐component coupling reactions to synthesize functionalized amines. Angewandte Chemie 2022; 134: [View Article]
    [Google Scholar]
  35. Costa Silva RA, da Silva CR, de Andrade Neto JB, da Silva AR, Campos RS et al. In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates. Microb Pathog 2017; 107:341–348 [View Article]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001664
Loading
/content/journal/jmm/10.1099/jmm.0.001664
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error